Swiss offer Geneva space for WHO pathogen exchange
WHO director general Tedros Ghebreyesus thanked Switzerland for offering a secure lab in Geneva.
Keystone / Martial Trezzini
Switzerland has offered secure space for the Geneva-based WHO to store pathogen materials as part of a proposed new global mechanism for sharing pathogens in the fight against Covid-19.
This content was published on
2 minutes
Keystone-SDA/Reuters/jc
“The pandemic has shown that there is an urgent need for a globally agreed system for sharing pathogen materials and clinical samples, to facilitate the rapid development of medical countermeasures as global public goods,” World Health Organization director-general Tedros Ghebreyesus said on Friday.
Speaking in closing remarks to a virtual WHO Assembly, he stressed this was needed quickly.
The WHO is proposing “a new approach that would include a repository for materials housed by WHO in a secure Swiss facility; an agreement that sharing materials into this repository is voluntary; that WHO can facilitate the transfer and use of the materials; and a set of criteria under which WHO would distribute them”.
Ghebreyesus said a number of countries had shown interest. He thanked Swiss health minister Alain Berset and the federal government “for offering a BSL 4 lab to support this initiative”.
COVAX on track
Meanwhile, the COVAX vaccine pool led by WHO and the Gavi Vaccine Alliance said on Friday it has exceeded its interim target of raising more than $2 billion (CHF1.83 billion) to buy and distribute Covid-19 vaccines for poorer countries.
These funds will allow COVAX to buy an initial one billion vaccine doses for 92 eligible countries that would not otherwise be able to afford them, according to a Gavi statement. But it said a further $5 billion will be needed in 2021 to buy Covid-19 vaccine doses as they come through development and are approved by regulators.
Gavi chief Seth Berkley also told journalists on Friday that US drugmaker Pfizer and its partner BioNTech, who this week said their Covid-19 vaccine was 90% effective in initial trials, had expressed interest in supplying doses to COVAX.
Popular Stories
More
Swiss Abroad
The citizenship obstacle course facing spouses of Swiss Abroad
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
Eurovision and bleak world situation are top themes at Basel carnival
This content was published on
The Eurovision Song Contest and the gloomy global situation are among the main themes of Basel Fasnacht (carnival) this year.
Prices of Swiss investment properties continue to rise despite stagnating rents
This content was published on
Although rents in Switzerland stagnated or fell in the final quarter of last year, prices for investment properties continued to rise. Both apartment buildings and office properties have become more expensive.
Probe into wrong Swiss pension figures clears federal office
This content was published on
Employees of the Swiss Federal Social Insurance Office (FSIO) did not breach their duty of care when calculating pension prospects, an investigation has concluded.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Why Swiss participation in WHO’s Covid-19 vaccine plan matters
This content was published on
As the second coronavirus wave makes finding vaccines even more urgent, we look at Swiss participation in the WHO's vaccine pool.
This content was published on
Switzerland confirms participation in WHO COVAX initiative aimed at ensuring equitable access to Covid-19 vaccines when they are approved.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.